vs

Side-by-side financial comparison of AstroNova, Inc. (ALOT) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $39.2M, roughly 1.1× AstroNova, Inc.). AstroNova, Inc. runs the higher net margin — 1.0% vs -90.4%, a 91.4% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -3.4%). AstroNova, Inc. produced more free cash flow last quarter ($3.3M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs 2.1%).

AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

ALOT vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.1× larger
PACB
$44.6M
$39.2M
ALOT
Growing faster (revenue YoY)
PACB
PACB
+17.2% gap
PACB
13.8%
-3.4%
ALOT
Higher net margin
ALOT
ALOT
91.4% more per $
ALOT
1.0%
-90.4%
PACB
More free cash flow
ALOT
ALOT
$23.3M more FCF
ALOT
$3.3M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
2.1%
ALOT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ALOT
ALOT
PACB
PACB
Revenue
$39.2M
$44.6M
Net Profit
$378.0K
$-40.4M
Gross Margin
36.2%
37.1%
Operating Margin
3.3%
-92.3%
Net Margin
1.0%
-90.4%
Revenue YoY
-3.4%
13.8%
Net Profit YoY
221.5%
-1802.7%
EPS (diluted)
$0.05
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALOT
ALOT
PACB
PACB
Q4 25
$39.2M
$44.6M
Q3 25
$36.1M
$38.4M
Q2 25
$37.7M
$39.8M
Q1 25
$37.2M
Q4 24
$40.4M
$39.2M
Q3 24
$40.5M
$40.0M
Q2 24
$33.0M
$36.0M
Q1 24
$39.6M
$38.8M
Net Profit
ALOT
ALOT
PACB
PACB
Q4 25
$378.0K
$-40.4M
Q3 25
$-1.2M
$-38.0M
Q2 25
$-376.0K
$-41.9M
Q1 25
$-426.1M
Q4 24
$240.0K
$2.4M
Q3 24
$-311.0K
$-60.7M
Q2 24
$1.2M
$-173.3M
Q1 24
$2.7M
$-78.2M
Gross Margin
ALOT
ALOT
PACB
PACB
Q4 25
36.2%
37.1%
Q3 25
32.2%
41.4%
Q2 25
33.6%
36.9%
Q1 25
-3.7%
Q4 24
33.9%
25.6%
Q3 24
35.3%
25.0%
Q2 24
36.3%
16.5%
Q1 24
31.9%
29.1%
Operating Margin
ALOT
ALOT
PACB
PACB
Q4 25
3.3%
-92.3%
Q3 25
-2.0%
-101.1%
Q2 25
1.5%
-112.8%
Q1 25
-1154.5%
Q4 24
3.1%
-390.1%
Q3 24
2.6%
-160.3%
Q2 24
4.1%
-488.3%
Q1 24
9.9%
-209.6%
Net Margin
ALOT
ALOT
PACB
PACB
Q4 25
1.0%
-90.4%
Q3 25
-3.4%
-98.9%
Q2 25
-1.0%
-105.4%
Q1 25
-1146.8%
Q4 24
0.6%
6.0%
Q3 24
-0.8%
-151.9%
Q2 24
3.6%
-481.3%
Q1 24
6.8%
-201.4%
EPS (diluted)
ALOT
ALOT
PACB
PACB
Q4 25
$0.05
$-0.11
Q3 25
$-0.16
$-0.13
Q2 25
$-0.05
$-0.14
Q1 25
$-1.44
Q4 24
$0.03
$-0.44
Q3 24
$-0.04
$-0.22
Q2 24
$0.15
$-0.64
Q1 24
$0.37
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALOT
ALOT
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$3.6M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$76.9M
$5.3M
Total Assets
$140.8M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALOT
ALOT
PACB
PACB
Q4 25
$3.6M
$279.5M
Q3 25
$3.9M
$298.7M
Q2 25
$5.4M
$314.7M
Q1 25
$343.1M
Q4 24
$4.4M
$389.9M
Q3 24
$4.8M
$471.1M
Q2 24
$4.0M
$509.8M
Q1 24
$4.5M
$561.9M
Stockholders' Equity
ALOT
ALOT
PACB
PACB
Q4 25
$76.9M
$5.3M
Q3 25
$75.8M
$36.1M
Q2 25
$76.6M
$61.5M
Q1 25
$91.6M
Q4 24
$92.2M
$506.6M
Q3 24
$91.8M
$453.1M
Q2 24
$91.2M
$492.7M
Q1 24
$90.3M
$649.0M
Total Assets
ALOT
ALOT
PACB
PACB
Q4 25
$140.8M
$784.1M
Q3 25
$143.1M
$803.2M
Q2 25
$150.3M
$825.5M
Q1 25
$860.8M
Q4 24
$166.5M
$1.3B
Q3 24
$169.0M
$1.5B
Q2 24
$126.6M
$1.5B
Q1 24
$133.3M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALOT
ALOT
PACB
PACB
Operating Cash FlowLast quarter
$3.4M
$-19.1M
Free Cash FlowOCF − Capex
$3.3M
$-19.9M
FCF MarginFCF / Revenue
8.5%
-44.6%
Capex IntensityCapex / Revenue
0.2%
1.9%
Cash ConversionOCF / Net Profit
9.05×
TTM Free Cash FlowTrailing 4 quarters
$2.9M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALOT
ALOT
PACB
PACB
Q4 25
$3.4M
$-19.1M
Q3 25
$249.0K
$-18.7M
Q2 25
$4.4M
$-29.4M
Q1 25
$-44.1M
Q4 24
$-4.7M
$-30.6M
Q3 24
$162.0K
$-45.5M
Q2 24
$6.9M
$-54.3M
Q1 24
$6.5M
$-75.7M
Free Cash Flow
ALOT
ALOT
PACB
PACB
Q4 25
$3.3M
$-19.9M
Q3 25
$202.0K
$-18.8M
Q2 25
$4.3M
$-29.9M
Q1 25
$-45.4M
Q4 24
$-5.0M
$-32.3M
Q3 24
$-176.0K
$-46.3M
Q2 24
$6.4M
$-55.7M
Q1 24
$6.0M
$-79.6M
FCF Margin
ALOT
ALOT
PACB
PACB
Q4 25
8.5%
-44.6%
Q3 25
0.6%
-48.9%
Q2 25
11.5%
-75.3%
Q1 25
-122.3%
Q4 24
-12.4%
-82.3%
Q3 24
-0.4%
-115.7%
Q2 24
19.5%
-154.8%
Q1 24
15.3%
-205.0%
Capex Intensity
ALOT
ALOT
PACB
PACB
Q4 25
0.2%
1.9%
Q3 25
0.1%
0.2%
Q2 25
0.2%
1.4%
Q1 25
3.7%
Q4 24
0.6%
4.1%
Q3 24
0.8%
2.0%
Q2 24
1.5%
4.1%
Q1 24
1.0%
10.0%
Cash Conversion
ALOT
ALOT
PACB
PACB
Q4 25
9.05×
Q3 25
Q2 25
Q1 25
Q4 24
-19.76×
-12.93×
Q3 24
Q2 24
5.85×
Q1 24
2.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALOT
ALOT

Public Utilities Inventory Supplies$20.6M53%
Hardware Products$12.7M32%
Service And Other$5.9M15%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons